Cibc World Market Inc. Astrazeneca PLC Transaction History

Cibc World Market Inc.

$47.7 Billion
Q4 2024

A detailed history of Cibc World Market Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Cibc World Market Inc. holds 46,188 shares of AZN stock, worth $3.41 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

46,188

Previous 94,732 51.24%

Holding current value

$3.41 Million

Previous $7.38 Million 59.0%

% of portfolio

0.01%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	SELL	$63.2 - $79.58 $3.07 Million - $3.86 Million	-48,544 Reduced 51.24%	46,188 $3.03 Million
Q3 2024 Nov 12, 2024	BUY	$76.67 - $87.62 $546,043 - $624,029	7,122 Added 8.13%	94,732 $7.38 Million
Q2 2024 Aug 07, 2024	BUY	$66.81 - $80.83 $3.62 Million - $4.39 Million	54,257 Added 162.68%	87,610 $6.83 Million
Q1 2024 May 13, 2024	SELL	$61.03 - $69.57 $125,843 - $143,453	-2,062 Reduced 5.82%	33,353 $2.26 Million
Q4 2023 Feb 13, 2024	SELL	$61.89 - $69.28 $338,043 - $378,407	-5,462 Reduced 13.36%	35,415 $2.39 Million
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $23,151 - $25,596	-357 Reduced 0.87%	40,877 $2.77 Million
Q2 2023 Aug 11, 2023	BUY	$69.91 - $75.81 $411,210 - $445,914	5,882 Added 16.64%	41,234 $2.95 Million
Q1 2023 May 12, 2023	BUY	$63.15 - $71.6 $104,829 - $118,855	1,660 Added 4.93%	35,352 $2.45 Million
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $2.71 Million - $3.52 Million	-49,949 Reduced 59.72%	33,692 $2.28 Million
Q3 2022 Nov 10, 2022	SELL	$53.02 - $135.75 $1.89 Million - $4.84 Million	-35,624 Reduced 29.87%	83,641 $4.59 Million
Q2 2022 Aug 10, 2022	SELL	$59.26 - $71.14 $132,505 - $159,069	-2,236 Reduced 1.84%	119,265 $7.88 Million
Q1 2022 May 12, 2022	BUY	$55.72 - $67.12 $4.93 Million - $5.93 Million	88,392 Added 266.97%	121,501 $8.06 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $12,208 - $14,425	-226 Reduced 0.68%	33,109 $1.93 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $72,172 - $78,966	1,299 Added 4.05%	33,335 $2 Million
Q2 2021 Aug 12, 2021	SELL	$48.42 - $60.18 $1.05 Million - $1.31 Million	-21,736 Reduced 40.42%	32,036 $1.92 Million
Q1 2021 May 11, 2021	SELL	$47.16 - $54.44 $1.19 Million - $1.38 Million	-25,300 Reduced 32.0%	53,772 $2.67 Million
Q4 2020 Feb 08, 2021	BUY	$48.52 - $58.02 $127,219 - $152,128	2,622 Added 3.43%	79,072 $3.95 Million
Q3 2020 Nov 12, 2020	BUY	$53.07 - $61.1 $163,031 - $187,699	3,072 Added 4.19%	76,450 $4.19 Million
Q2 2020 Aug 13, 2020	BUY	$43.1 - $55.31 $558,360 - $716,541	12,955 Added 21.44%	73,378 $3.88 Million
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $414,480 - $562,987	-10,968 Reduced 15.36%	60,423 $2.7 Million
Q4 2019 Feb 13, 2020	BUY	$42.46 - $50.46 $484,638 - $575,950	11,414 Added 19.03%	71,391 $3.56 Million
Q3 2019 Nov 13, 2019	BUY	$40.12 - $45.47 $109,928 - $124,587	2,740 Added 4.79%	59,977 $2.67 Million
Q2 2019 Aug 08, 2019	SELL	$37.28 - $41.68 $82,500 - $92,237	-2,213 Reduced 3.72%	57,237 $2.36 Million
Q1 2019 May 09, 2019	SELL	$35.49 - $43.02 $1.21 Million - $1.47 Million	-34,187 Reduced 36.51%	59,450 $2.4 Million
Q4 2018 Feb 13, 2019	BUY	$36.86 - $41.49 $270,957 - $304,992	7,351 Added 8.52%	93,637 $3.56 Million
Q3 2018 Nov 09, 2018	BUY	$34.76 - $39.72 $28,016 - $32,014	806 Added 0.94%	86,286 $3.41 Million
Q2 2018 Aug 08, 2018	SELL	$34.55 - $37.05 $30,023 - $32,196	-869 Reduced 1.01%	85,480 $3 Million
Q1 2018 May 18, 2018	BUY	$32.97 - $36.63 $1.65 Million - $1.83 Million	50,024 Added 137.71%	86,349 $3.02 Million
Q4 2017 Feb 01, 2018	BUY	$32.09 - $34.78 $203,867 - $220,957	6,353 Added 21.2%	36,325 $1.26 Million
Q3 2017 Nov 13, 2017	BUY	$28.96 - $34.0 $867,989 - $1.02 Million	29,972	29,972 $1.02 Million

Others Institutions Holding AZN

# of Institutions

1,355

Shares Held

512M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $229B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.

Account

Cibc World Market Inc. Astrazeneca PLC Transaction History